Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.
Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van 't Hof AW; Zwolle Myocardial Infarction Study Group. Timmer JR, et al. Among authors: gosselink at. J Am Coll Cardiol. 2005 Apr 5;45(7):999-1002. doi: 10.1016/j.jacc.2004.12.050. J Am Coll Cardiol. 2005. PMID: 15808754 Free article.
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ. van 't Hof AW, et al. Among authors: gosselink at. Eur Heart J. 2003 Aug;24(15):1401-5. doi: 10.1016/s0195-668x(03)00259-8. Eur Heart J. 2003. PMID: 12909068 Clinical Trial.
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure.
De Luca G, van 't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, Ottervanger JP, Zijlstra F, Suryapranata H. De Luca G, et al. Among authors: gosselink at. Circulation. 2004 Mar 2;109(8):958-61. doi: 10.1161/01.CIR.0000120504.31457.28. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981008
Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: an angiographic risk score for use in the catheterization laboratory.
Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, Dambrink JH, Gosselink AT, van 't Hof AW, Hoorntje JC, Suryapranata H. Henriques JP, et al. Among authors: gosselink at. Catheter Cardiovasc Interv. 2004 Mar;61(3):338-43. doi: 10.1002/ccd.10781. Catheter Cardiovasc Interv. 2004. PMID: 14988892
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW. Ernst NM, et al. Among authors: gosselink at. J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050. J Am Coll Cardiol. 2004. PMID: 15364318 Free article. Clinical Trial.
130 results